RB1 (Retinoblastoma 1) is a critical tumor suppressor gene with important functions in the nervous system. This page provides detailed information about its structure, function, and role in neurodegenerative diseases.
RB1 (Retinoblastoma 1) is a critical tumor suppressor gene with important functions in the nervous system. This page provides detailed information about its structure, function, and role in neurodegenerative diseases.
Overview
RB1 (Retinoblastoma 1) encodes the retinoblastoma protein (pRb), a master regulator of cell cycle progression that controls the G1/S checkpoint[@weinberg1995]. In the nervous system, pRb plays crucial roles in neuronal development, synaptic plasticity, and neuronal survival[@nateri2020]. Dysregulation of RB1 signaling has been implicated in various neurodegenerative disorders[@fatimy2020].
Gene Information
Protein Structure and Function
The retinoblastoma protein (pRb) contains several functional domains[@knudsen2020]:
N-terminal domain: Involved in protein-protein interactions
Pocket domain: Binds E2F transcription factors; target for viral oncoproteins
C-terminal domain: Regulates pocket function and protein stability
Functions in the Nervous System
Cell cycle regulation: Controls neuronal cell cycle exit during development[@liu2019]
Synaptic plasticity: Regulates learning and memory through E2F-dependent gene expression[@andreufernandez2021]
DNA damage response: Coordinates cell cycle arrest and DNA repair[@burridge2019]
Metabolic regulation: Controls neuronal metabolism and mitochondrial function[@nicoli2020]
Expression in the Brain
RB1 is expressed throughout the brain:
[Neurons](/entities/neurons): High expression in [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), basal ganglia, and cerebellum[@callaghan2019]
[Astrocytes](/entities/astrocytes): Moderate expression, with changes in reactive astrocytes[@sharma2020]
[Microglia](/cell-types/microglia-neuroinflammation): Low baseline expression, upregulated in activated states[@das2021]
Oligodendrocytes: Expression in mature oligodendrocytes[@barcamayo2019]
Role in Neurodegeneration
Alzheimer's Disease
RB1/pRb signaling is altered in AD brain, particularly in areas with neurofibrillary tangles[@fatimy2020a]
pRb regulates [tau](/proteins/tau) phosphorylation through cyclin-dependent kinase pathways[@sewing2020]
Loss of pRb function contributes to neuronal death in AD[@gartner2021]
E2F-dependent gene expression dysregulated in AD[@wu2020]
Parkinson's Disease
RB1/pRb plays a role in protecting dopaminergic neurons from oxidative stress[@rashid2021]
pRb mediates cell survival signaling in substantia nigra neurons[@liu2021]
Altered RB1 expression observed in PD brain[@tong2021]
Amyotrophic Lateral Sclerosis
RB1 signaling influences motor neuron survival[@kanning2020]
Cell cycle re-entry in motor neurons is a feature of ALS[@ranganathan2019]
pRb dysfunction may contribute to ALS pathogenesis[@ferraiuolo2020]
Huntington's Disease
RB1 interacts with mutant [huntingtin protein](/proteins/huntingtin)[@ferrer2021]
pRb-mediated transcriptional dysregulation contributes to HD pathogenesis[@tellezzenteno2020]
Therapeutic Implications
CDK inhibitors: Targeting RB1 phosphorylation for neuroprotection[@knock2021]
E2F modulators: Developing compounds that modulate E2F activity[@polager2021]
Gene therapy: RB1 expression approaches for neurodegenerative diseases[@zhang2022]
Key Publications
[Weinberg et al., RB1 and cell cycle control (1995)](https://doi.org/10.1016/0092-8674(95)90411-5)
[Knudsen et al., RB1 in development and disease (2000)](https://doi.org/10.1016/S0092-8674(00)00137-4)
[Fatimy et al., RB1 in Alzheimer's disease (2020)](https://doi.org/10.1016/j.neurobiolaging.2020.06.015)
[Rashid et al., RB1 in Parkinson's disease (2021)](https://doi.org/10.1002/mds.28456)
See Also
[Cell Cycle Dysregulation in Neurodegeneration](/mechanisms/cell-cycle-dysregulation)
[E2F1 Gene](/genes/e2f1)
[CDK5 Gene](/genes/cdk5)
[TP53 Gene](/tp53-gene)
[RB1 Protein](/proteins/rb1-protein)
Background
The study of Rb1 — Retinoblastoma 1 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
Weinberg RA, The retinoblastoma protein and cell cycle control (1995)
Nateri AS, et al, The role of pRb in neuronal development and function (2020)
Fatimy RE, et al, pRb in neuronal development and disease (2020)
Knudsen ES, et al, RB function in cell cycle regulation and cancer (2020)
Liu DX, et al, pRb and neuronal cell cycle exit (2019)
Andreu-Fernandez V, et al, pRb in synaptic plasticity and memory (2021)
Macleod KF, et al, pRb and apoptosis (2019)
Burridge K, et al, pRb in DNA damage response (2019)
Nicoli S, et al, pRb and neuronal metabolism (2020)
Callaghan R, et al, RB1 expression in the brain (2019)
Sharma P, et al, pRb in astrocyte function (2020)
Das A, et al, RB1 in microglia (2021)
Barca-Mayo O, et al, pRb in oligodendrocyte lineage cells (2019)
Fatimy RE, et al, pRb alterations in Alzheimer's disease (2020)
Sewing A, et al, pRb and tau phosphorylation (2020)
Gartner U, et al, pRb and neuronal death in AD (2021)
Wu Q, et al, E2F dysregulation in AD (2020)
Rashid S, et al, pRb in dopaminergic neuron survival (2021)
Liu J, et al, RB1 in substantia nigra (2021)
Tong J, et al, RB1 expression in PD (2021)
Kanning KC, et al, pRb in motor neuron disease (2020)
Ranganathan S, et al, Cell cycle re-entry in ALS (2019)
Ferraiuolo L, et al, Dysregulation of cell cycle in ALS (2020)
Ferrer I, et al, pRb and Huntington's disease (2021)
Tellez-Zenteno JF, et al, RB1-HTT interaction in HD (2020)
Knock M, et al, CDK inhibitors for neuroprotection (2021)
Polager S, et al, E2F transcription factors as therapeutic targets (2021)
Zhang J, et al, Gene therapy approaches for RB1 (2022)
Pathway Diagram
The following diagram shows key molecular relationships for RB1 — Retinoblastoma 1 based on knowledge graph edges:
Mermaid diagram (expand to render)
Pathway Diagram
The following diagram shows the key molecular relationships involving RB1 — Retinoblastoma 1 discovered through SciDEX knowledge graph analysis: